abstract |
Use of immune effector cells (eg, T cells, NK cells), eg, engineered to express a chimeric antigen receptor (CAR), to treat a subject having a disease, eg, a disease associated with expression of a tumor antigen And the use of LSD1 inhibitors in connection with manufacturing is provided herein. |